|
GeneExpression Systems & Appasani Research Conferences (ARCEI-US.ORG)
Jointly Presents
Sixth International
Stem Cells & Cell Signaling - 2013 Meeting
On
‘Assays to Regenerative Medicine, Tissue Engineering & Therapeutics’
May 1-2, 2012
Venue: Hilton Garden Inn, 420 Totten Pond Road, Waltham 02451, USA
This meeting will be held in Conjunction with RNAi, Single Cell Biology and Optogenetics-2013-Meetings.
“Unique Themes to Combine, Stem Cell Biology and Cell Signaling”
| Expected Maximum Capacity: |
| Target Audience |
100 |
| Total Speaker Presentations: |
30 |
| Total Poster Presentations: |
15 |
| Total Exhibit Booths: |
15 |
Key Sessions:
Self-renewal and Maintenance
Stem Cells Propagation Techniques & Novel Reagents
Biopolymer Applications in Tissue Engineering
Epigenetic & Transcriptional Controls of Stem Cells
Signaling Mechanisms in Stem Cells
Tissue Organ Culture and Transplantation
Applications of Stem Cells to Human Diseases
Click Here for AGENDA/SPEAKERS
Wendnesday, May 1, 2013
8 A.M: Registration Open
8:45 – 6:00 PM: Scientific Sessions
Thursday, May 2, 2013
8 A.M: Registration Open
9:00 – 6:00 PM: Scientific Sessions
Scientific Organizer:
 |
Krishnarao Appasani, Ph.D., MBA
Founder & CEO
GeneExpression Systems, Inc,
Waltham, MA, USA |
Keynote Speaker:
 |
David T. Scadden, Jr., MD.
Gerald and Darlene Jordan Professor of Medicine
Director, Center for Regenerative Medicine, Massachusetts General Hospital
Co-Director, Harvard Stem Cell Institute,
Harvard University Medical School
Chief, Hematologic Malignancies, MGH Cancer Center, Boston, Massachusetts, USA
Title: Heamatopoietic stem cells |
Other Speakers:
 |
Jeffrey M. Karp, PhD.
Associate Professor, Harvard Medical School
Brigham and Women's Hospital & Harvard Stem Cell Institute
Cambridge, Massachusetts, USA
Title: Towards Bioengineered Control of Cell Fate Post Transplantation |
 |
Kenji Yasuda, PhD.
Professor of Bioengineering
Tokyo Medical and Dental University
Tokyo, Japan
Title: On-chip quasi-in vivo cardiomyocyte network screening assay for predictive cardiotoxicity beyond hERG and QT assays |
 |
Emma Baker, PhD.
Cure Cancer Australia Research Fellow
St. Vincent's Institute
Fitzroy, VIC, Australia
Title: Understanding and manipulating the epigenetic networks that define osteosarcoma |
 |
Peter Sartipy, PhD.
Senior Principal Scientist
Cellartis AB
Göteborg, Sweden
Title: Human cardiomyocytes derived from pluripotent stem cells: In vitro tools and disease models |
 |
Randy Yerden
Chief Executive Officer
BioSpherix, Ltd.
Lacona, New York, USA
Title: Better manufacturing practice for cell therapies |
 |
Shi-Jiang (John) Lu, PhD, MPH
Senior Director for Research
Advanced Cell Technology
Marlborough, MA, USA
Title: Blood Cells from Pluripotent Stem Cells: The Promise and Challenge for Clinical Application |
 |
Eric M. Darling, PhD.
Assistant Professor of Medical Science
Center for Biomedical Engineering
Brown University
Providence, Rhode Island, USA
Title: Molecular beacons as indicators of osteogenic differentiation in live stem cells |
 |
Natalia B. Ivanova PhD.
Assistant Professor of Genetics
Yale University,Yale Stem Cell Center
New Haven, CT, USA
Title: Specification Roles for NANOG, OCT4, and SOX2 in Human Embryonic Stem Cells |
 |
Rodney J. Nash, PhD.
President & CEO
Jeevan Biosciences, Inc.
Dunwoody, Georgia, USA
Title: Glioblastoma-derived cancer stem cells can be used in ADME/Toxicology drug development |
 |
Angelo L. Vescovi, PhD.
Professor of Cell Biology
University of Milano-Bicocca
Milano, Italy
Title: Cancer stem cells from human glioblastomas for the development of novel bio-therapeutics |
 |
Ren-He Xu, MD, PhD.
Associate Professor
University of Connecticut Health Center
Farmington, Connecticut, USA
Title: Epigenetic regulation of miR-302 to initiate neural differentiation |
 |
George J. Murphy, PhD.
Assistant Professor of Medicine &
Boston University School of Medicine
Boston, MA, USA
Title: Pluripotent stem cell modeling of human disease |
 |
Duane R. Wesemann, MD, PhD.
Associate Physician
Instructor at the Harvard Medical School
Immune Disease Institute & Children’s Hospital
Boston, Massachusetts, USA
Title: Reprogramming IgH isotype-switched B cells to functional grade induced pluripotent stem cells |
 |
James L. Sherley, MD, PhD.
Sr.Scientist in Regenerative Biol. & Cancer Biology
Boston Biomedical Research Institute
Watertown, MA, USA
Title: A proposed mechanism for the specification and maintenance of immortal DNA strands in asymmetrically self-renewing distributed stem cells |
 |
Mehmet Fatih Yanik, PhD.
Associate Professor of Electrical Engg.
Massachusetts Institute of Technology
Cambridge, MA, USA
Title: mRNA delivery for nuclear reprogramming |
 |
James Monaghan, PhD.
Assistant Professor of Biology
Northeastern University
Boston, MA, USA
Title: Tissue regeneration |
 |
Julie B. Sneddon, PhD.
Post-doctoral Fellow
Harvard University
Cambridge, MA, USA
Title: Self-renewal of ESC-derived progenitors by organ-matched mesenchyme |
 |
Krzysztof Kobielak, MD, PhD.
Assistant Professor of Pathology
University of Southern California-Keck School of Medicine, Los Angeles, California, USA
Title: BMP/Wnt signaling in stem cell gene networks of cycling hair follicle |
 |
Dr. Suzanne E. Berry-Miller
Assistant Professor of Neuroscience
University of Illinois, Urbana, IL, USA
Title: Healing a broken heart; stem cell therapy for dilated cardiomyoapthy in Duchenne muscular dystrophy |
 |
Ed. Lu, PhD, MBA.
Cellular and Molecular Sciences
HealthPoint Biotherapeutics, Inc.
Title: Spray-applied Cell therapy for the treatment of Chronic Venous Leg Ulcer – Production transition from clinical trials to commercial distribution |
 |
Xue-Jun (June) Li, PhD.
Assistant Professor of Neuroscience
The University of Connecticut Health Center
Farmington, CT, USA
Title: Modeling motor neuron degeneration using human pluripotent stem cells |
 |
Haruhisa Inoue, MD, PhD.
Associate Professor
CiRA, Kyoto University
Kyoto, Japan
Title: Modeling Alzheimer's disease using patient-specific iPSCs reveals stress phenotypes |
 |
Caroline N. Dealy, PhD.
Associate Professor & Chief Scientific Officer
University of Connecticut Stem Cell Institute & Chondrogenics, Inc.
Farmington, CT 06030 USA
Title: Developing a potential therapy for Osteoarthritic cartilage damage using hESC-derived chondrogenic cells |
 |
Casey Gifford, PhD Student
Dr. Meissner Lab
Harvard University & The Broad Institute
Cambridge MA, USA
Title: Transcriptional and epigenetic dynamics during specification of Human embryonic stem cells |
Exhibitors are welcome to reserve their booth space early!
Please contact if you are interested in speaking in the scientific or Technology workshops of this meeting.
GeneExpression Systems, Inc.
P.O. Box 540170
Waltham, MA 02454 USA
Tel: (781) 891-8181
Fax: (781)730-0700 or (781) 891-8234
E-mail: Genexpsys@expressgenes.com
www.expressgenes.com
Note: Speakers Names, Titles and venue subjected to change beyond our control for which the company is not responsible.
For Oral Presentation Abstracts Due By: Jan 31, 2013
For Poster Presentation Abstracts Due By: Apri 25, 2013
Email your abstract (100-200 words in word format) to: genexpsys@expressgenes.com
 |
